A decision Friday by the US Food and Drug Administration's vaccine advisers to recommend emergency use authorization of a booster dose for people 65 and older and those at high risk of severe Covid-19 was "an important step forward," the White House said.
“Today was an important step forward in providing better protection to Americans from COVID-19. We stand ready to provide booster shots to eligible Americans once the process concludes at the end of next week,” White House spokesperson Kevin Munoz said.
Some background: The decision came after members of the FDA's Vaccines and Related Biological Products Advisory Committee rejected a broader application to approve booster doses of Pfizer's vaccines in everyone 16 and older six months after they are fully vaccinated. Members of the committee expressed doubts about the safety of a booster dose in younger adults and teens, and complained about the lack of data about the safety and long term efficacy of a booster dose.